Approvals/TGA/DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 100mg/20mL

Approved

STANDARD

DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 100mg/20mL

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bbface0d838f46fe
Product Name: DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 100mg/20mL
Artg Id: 131758
Artg Name: DBL OXALIPLATIN oxaliplatin concentrate for infusion 100mg/20mL vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2009-02-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01963-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01867-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bbface0d838f46fe

Type

Standard